Drugs@FDA document

ATROPEN Letter · NDA 017106 SUPPL-32

Drugs@FDA document · MMT · Sep 21, 2004

Key facts

Drug name ATROPEN
Document type Letter
Application NDA017106
Submission SUPPL-32
Company MMT
Document date Sep 21, 2004
FDA document accessdata.fda.gov

At a glance

  • Manufacturing (CMC)-Formulation Document categories
  • 1–9 Documents for this application
  • None USP chapters cited in this application's documents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA documents

Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date:

Browse all Drugs@FDA documents